A mother who was left with sagging breasts after losing 70 pounds (5th) with weight loss strokes says she is not “ashamed” of having a tummy tuck and breast lift.
Courtney Kleinebreil of Arkansas was “fed up” with weighing more than 300 pounds and in 2021 vowed to give herself six months to “get healthy.”
After switching to a low-carb diet, her doctor recommended that the 28-year-old start taking Wegovy to accelerate her weight loss and then switched to Mounjaro.
In June 2023, when she stopped the injections, she had almost 6 pounds (2.7 kg) of excess skin left on her stomach, which she described as a “bag.”
Last July, Mrs. Kleinebreil, who has three children, took the plunge and underwent a cosmetic procedure to tighten her stomach muscles.
Courtney Kleinebreil of Arkansas was “fed up” with weighing more than 300 pounds and in 2021 vowed to give herself six months to “get healthy.” After switching to a low-carb diet, her doctor recommended that the 28-year-old start taking Wegovy to speed up her weight loss and then switched to Mounjaro.
In June 2023, when she stopped the injections, she was left with almost 6 pounds (2.7 kg) of excess skin on her stomach, which she described as a “bag.”
Last July, Mrs. Kleinebreil, who has three children, took the plunge and underwent a cosmetic procedure to tighten her stomach muscles. Earlier this year, she underwent a breast lift with fat transfer to fix her ‘deflated’ triple D breasts, and she detailed her journey on social media.
Earlier this year, she underwent a fat transfer breast lift to fix her ‘deflated’ triple D breasts, and detailed her journey on social media.
She told her 527,000 TikTok followers that they too were “very low” and “unbalanced” after her dramatic weight loss.
After the surgery, she added that she was “very happy” and “already loving” the results.
Semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (Mounjaro) have been hailed as a monumental advance in the war against obesity.
Feathers, taken once a day, trick the brain into thinking it is full, curbing appetite.
Trials show that semaglutide, made by the Danish company Novo Nordisk, helps users lose up to 33 pounds (15.3 kg) on average in about a year.
Meanwhile, studies on Mounjaro, carried out by US pharmaceutical giant Eli Lilly, suggest the drug could help obese people lose up to 22.5 per cent of their body weight in 72 weeks.
However, top plastic surgeons are reporting an increase in the number of patients seeking touch-ups after losing weight rapidly with medication, and warn that without these operations many would be left disfigured or even disabled.
Sudden fat loss also causes a number of body problems, with middle-aged and older users being the most affected.
A growing number of Ozempic users on social media complain of gaunt facial features, sagging “melted candle” skin, “empty” breasts and hair loss, which are not believed to be a direct side effect of the medication. but a consequence of dramatic consequences. slim down.
Analysis suggests the cost of tackling the knock-on effects of the jabs on the NHS could rise to more than £100m a year.
Kleinebreil told his 527,000 TikTok followers: ‘I started taking Wegovy and this boosted my weight loss again. I had a very good experience with the medication.
‘I didn’t have any bad side effects; I just felt like it could help me with the cravings and food noise.
‘But three months after taking the medication, my husband changed jobs and, with that, we had a change in insurance. Suddenly, Wegovy was no longer covered by my new insurance plan. That’s when I started taking Mounjaro.
Following her surgery in July, she took to TikTok with before and after videos flaunting her incredible transformation. She said: “I will never ever be ashamed of this body with a stomach full of sagging skin,” adding that she was now “very happy with my body after the tummy tuck.”
“Overall, I lost 130 pounds during my weight loss journey, and I lost about 70 pounds when I was on the medications.”
Following her surgery in July, she took to TikTok with before and after videos flaunting her incredible transformation.
She said: “I will never ever be ashamed of this body with a stomach full of sagging skin,” adding that she was now “very happy with my body after the tummy tuck.”
Then in April, days after her second surgery, a breast lift, she said she was still “very swollen” but the pain level was “super manageable.”
speaking to Women’s healthMs Kleinebreil, who no longer takes these hits, said: “I try to focus on getting healthy things into my body and make sure I get enough protein in my diet.” I eat consciously, but I don’t follow everything.
‘I also continue to exercise. I really enjoy taking fitness classes and have started playing tennis again. I have learned to fall in love with moving my body.
“That doesn’t mean I was happy to stop taking Mounjaro; it’s hard to give up something that’s been helpful, but I’ve learned to make the most of my situation.”
Figures suggest that around a third of patients left with redundant skin folds develop infections or other serious skin conditions such as ulcers.
According to the latest data, digestive problems were the most common side effects of tirzepatide, the active ingredient in Mounjaro. These included about one in five participants who suffered from nausea and diarrhea, and about one in 10 reported vomiting or diarrhea.
A recent study found that the cost of treating a non-healing wound (including medications, nursing time and hospital treatment) could be up to £7,886 per patient.
Meanwhile, one in ten patients is likely to develop depression or anxiety, and one in 20 is severely affected.
Surgeons estimate the price of treating serious mental illnesses at almost £5,000 per patient per year.
The latest NHS data shows that 26 per cent of adults in England are obese and a further 38 per cent are overweight but not obese.
Experts have pointed to a lack of exercise and poor diets high in ultra-processed foods as key factors in the UK’s obesity epidemic.
Wegovy was approved by the NHS last year, specifically for weight loss.
But the eligibility criteria for people who want to get the drug on the NHS (for the standard prescription price of £9.90 in England) are strict.
Mounjaro was received the green light from the National Institute for Excellence in Health and Healthcare (Nice) to National Health Service Use in September for patients with type 2 diabetes who do not have the condition under control.
Health services do not yet use it for obesity.
But in February it became available privately in Britain, with clinics charging around £40 for a week’s supply.